888-776-0942 from 8 AM - 10 PM ET
NEW YORK , March 18, 2022 /PRNewswire/ -- The insulin delivery devices market 2030 revenue will likely be $39,371.8 million , compared to an estimated $16,008.0 million in 2021. According to the market report published by P&S Intelligence. Among all the devices used for administering this peptide hormone into the body, insulin pens are used the most. Pens are easier to use by individuals on themselves compared to syringes and cheaper compared to insulin pumps and other devices.
Moreover, reusable pens are cost-effective in the long run, as a single pen can be used for a long time just by simply changing the vial/refill. Therefore, seeing the growing popularity of these devices, companies that produce them are enhancing their sales and distribution network in countries with a large diabetic population, such as China and India . Similarly, in developed countries, technologically advanced pens and ample medical reimbursements on their purchase are available.
Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/insulin-delivery-devices/report-sample
Key Findings of Insulin Delivery Devices Market Report
In the years to come, market players will find numerous growth opportunities in the APAC region, which is home to the largest diabetic population in the world. This, combined with the increasing awareness on a strict care regimen, is propelling the sale of insulin delivery devices. Among the various kinds of insulin pens, pumps, and other devices, those meant for home use continue to be the most popular.
Browse detailed report on Insulin Delivery Devices Market Business Strategies, and Regional Outlook 2030
Thus, key insulin delivery devices market players, such as Becton, Dickinson and Company, Tandem Diabetes Care Inc., Medtronic plc, Biocon Ltd., Insulet Corporation, Eli Lilly and Company, Novo Nordisk A/S, Ypsomed Holding AG, Sanofi, F. Hoffmann-La Roche Ltd., Braun Melsungen AG, Wockhardt Ltd., and Gulf Pharmaceutical Industries, are doing more to target the at-home consumer base. A key move in this regard is the introduction of insulin delivery devices that do not require fingersticks for calibration.
Insulin Delivery Devices Market Segmentation Analysis
Insulin Delivery Devices Market by Type
Insulin Delivery Devices Market by Distribution Channel
Insulin Delivery Devices Market by End Use
Insulin Delivery Devices Market Regional Analysis
Human Insulin Market Revenue Estimation and Forecast Through 2030
Home Use Insulin Delivery Devices Market Revenue Estimation and Forecast Through 2030
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact: Prajneesh Kumar P&S Intelligence Phone: +1-347-960-6455 Email: [email protected] Web: https://www.psmarketresearch.com Follow Us: LinkedIn Twitter
SOURCE P&S Intelligence
More news releases in similar topics
Cision Distribution 888-776-0942 from 8 AM - 9 PM ET